Andrew Koff - Publications

Affiliations: 
Molecular Biology Weill Cornell Medical College, New York, NY, United States 
Area:
Biochemistry, Molecular Biology, Cell Biology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Li Q, Jiang B, Guo J, Shao H, Del Priore IS, Chang Q, Kudo R, Li Z, Razavi P, Liu B, Boghossian AS, Rees MG, Ronan MM, Roth JA, Donovan KA, ... ... Koff A, et al. INK4 tumor suppressor proteins mediate resistance to CDK4/6 kinase inhibitors. Cancer Discovery. PMID 34544752 DOI: 10.1158/2159-8290.CD-20-1726  0.303
2019 Dickson MA, Koff A, D'Angelo SP, Gounder MM, Keohan ML, Kelly CM, Chi P, Antonescu CR, Landa J, Qin L, Crago AM, Singer S, Tap WD. Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma. Journal of Clinical Oncology. 37: 11004-11004. DOI: 10.1200/Jco.2019.37.15_Suppl.11004  0.325
2018 Klein ME, Dickson MA, Antonescu C, Qin LX, Dooley SJ, Barlas A, Manova K, Schwartz GK, Crago AM, Singer S, Koff A, Tap WD. PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence. Oncogene. PMID 29789718 DOI: 10.1038/S41388-018-0332-Y  0.447
2018 Klein ME, Kovatcheva M, Davis LE, Tap WD, Koff A. CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought. Cancer Cell. PMID 29731395 DOI: 10.1016/J.Ccell.2018.03.023  0.354
2018 Kovatcheva M, Klein ME, Tap WD, Koff A. Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors. Molecular & Cellular Oncology. 5: e1384882. PMID 29404388 DOI: 10.1080/23723556.2017.1384882  0.309
2017 Kovatcheva M, Liao W, Klein ME, Robine N, Geiger H, Crago AM, Dickson MA, Tap WD, Singer S, Koff A. ATRX is a regulator of therapy induced senescence in human cells. Nature Communications. 8: 386. PMID 28855512 DOI: 10.1038/S41467-017-00540-5  0.47
2016 Dickson MA, Schwartz GK, Keohan ML, D'Angelo SP, Gounder MM, Chi P, Antonescu CR, Landa J, Qin LX, Crago AM, Singer S, Koff A, Tap WD. Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. Jama Oncology. PMID 27124835 DOI: 10.1001/Jamaoncol.2016.0264  0.34
2015 Kovatcheva M, Liu DD, Dickson MA, Klein ME, O'Connor R, Wilder FO, Socci ND, Tap WD, Schwartz GK, Singer S, Crago AM, Koff A. MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition. Oncotarget. 6: 8226-43. PMID 25803170 DOI: 10.18632/Oncotarget.3364  0.545
2014 Raheja R, Liu Y, Hukkelhoven E, Yeh N, Koff A. The ability of TRIM3 to induce growth arrest depends on RING-dependent E3 ligase activity. The Biochemical Journal. 458: 537-45. PMID 24393003 DOI: 10.1042/Bj20131288  0.4
2014 Liu Y, Raheja R, Yeh N, Ciznadija D, Pedraza AM, Ozawa T, Hukkelhoven E, Erdjument-Bromage H, Tempst P, Gauthier NP, Brennan C, Holland EC, Koff A. TRIM3, a tumor suppressor linked to regulation of p21 Waf1/Cip1 Oncogene. 33: 308-315. PMID 23318451 DOI: 10.1038/Onc.2012.596  0.417
2013 Pérez-Sanz J, Arluzea J, Matorras R, González-Santiago N, Bilbao J, Yeh N, Barlas A, Romin Y, Manova-Todorova K, Koff A, De La Hoz C. Increased number of multi-oocyte follicles (MOFs) in juvenile p27Kip1 mutant mice: Potential role of granulosa cells Human Reproduction. 28: 1023-1030. PMID 23300200 DOI: 10.1093/Humrep/Des436  0.351
2012 Hukkelhoven E, Liu Y, Yeh N, Ciznadija D, Blain SW, Koff A. Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma. The Journal of Biological Chemistry. 287: 38523-30. PMID 23007395 DOI: 10.1074/Jbc.M112.366542  0.458
2012 Miller JP, Yeh N, Hofstetter CP, Keskin D, Goldstein AS, Koff A. p27kip1 protein levels reflect a nexus of oncogenic signaling during cell transformation. The Journal of Biological Chemistry. 287: 19775-85. PMID 22511779 DOI: 10.1074/Jbc.M112.361972  0.404
2011 Ciznadija D, Liu Y, Pyonteck SM, Holland EC, Koff A. Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma. Cancer Research. 71: 6174-83. PMID 21844184 DOI: 10.1158/0008-5472.Can-11-1031  0.39
2011 Ciznadija D, Zhu XH, Koff A. Hdm2- and proteasome-dependent turnover limits p21 accumulation during S phase. Cell Cycle (Georgetown, Tex.). 10: 2714-23. PMID 21768776 DOI: 10.4161/Cc.10.16.16725  0.54
2010 Brill E, Gobble R, Angeles C, Lagos-Quintana M, Crago A, Laxa B, Decarolis P, Zhang L, Antonescu C, Socci ND, Taylor BS, Sander C, Koff A, Singer S. ZIC1 overexpression is oncogenic in liposarcoma. Cancer Research. 70: 6891-901. PMID 20713527 DOI: 10.1158/0008-5472.Can-10-0745  0.409
2010 See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A. Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. Oncogene. 29: 1720-31. PMID 20062078 DOI: 10.1038/Onc.2009.465  0.545
2009 Liu Y, Elf SE, Asai T, Miyata Y, Liu Y, Sashida G, Huang G, Di Giandomenico S, Koff A, Nimer SD. The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle (Georgetown, Tex.). 8: 3120-4. PMID 19755852 DOI: 10.4161/Cc.8.19.9627  0.464
2009 Liu L, Lee S, Zhang J, Peters SB, Hannah J, Zhang Y, Yin Y, Koff A, Ma L, Zhou P. CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. Molecular Cell. 34: 451-60. PMID 19481525 DOI: 10.1016/J.Molcel.2009.04.020  0.316
2009 Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J, Reva B, Koff A, Nimer SD. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell. 4: 37-48. PMID 19128791 DOI: 10.1016/J.Stem.2008.11.006  0.456
2007 Miller JP, Yeh N, Vidal A, Koff A. Interweaving the cell cycle machinery with cell differentiation. Cell Cycle (Georgetown, Tex.). 6: 2932-8. PMID 18000404 DOI: 10.4161/Cc.6.23.5042  0.487
2007 Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, Ghossein R, Singh B, Holland E, Koff A. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). The Embo Journal. 26: 4683-93. PMID 17948060 DOI: 10.1038/Sj.Emboj.7601886  0.479
2007 Smartt HJ, Guilmeau S, Nasser SV, Nicholas C, Bancroft L, Simpson SA, Yeh N, Yang W, Mariadason JM, Koff A, Augenlicht LH. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia. Gastroenterology. 133: 232-43. PMID 17631145 DOI: 10.1053/J.Gastro.2007.04.043  0.438
2007 Yeh N, Miller JP, Gaur T, Capellini TD, Nikolich-Zugich J, de la Hoz C, Selleri L, Bromage TG, van Wijnen AJ, Stein GS, Lian JB, Vidal A, Koff A. Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130. Molecular and Cellular Biology. 27: 5161-71. PMID 17502351 DOI: 10.1128/Mcb.02431-06  0.486
2007 Liu Y, Elf SE, Miyata Y, Sashida G, Deblasio AD, Liu Y, Koff A, Nimer SD. Regulation of Hematopoietic Stem Cell Quiescence - A Novel Role for p53. Blood. 110: 92-92. DOI: 10.1182/Blood.V110.11.92.92  0.442
2006 Hulit J, Lee RJ, Li Z, Wang C, Katiyar S, Yang J, Quong AA, Wu K, Albanese C, Russell R, Di Vizio D, Koff A, Thummala S, Zhang H, Harrell J, et al. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling. Cancer Research. 66: 8529-41. PMID 16951165 DOI: 10.1158/0008-5472.Can-06-0149  0.409
2006 Refik-Rogers J, Manova K, Koff A. Misexpression of cyclin B3 leads to aberrant spermatogenesis. Cell Cycle (Georgetown, Tex.). 5: 1966-73. PMID 16929180 DOI: 10.4161/Cc.5.17.3137  0.726
2006 Guidi CJ, Mudhasani R, Hoover K, Koff A, Leav I, Imbalzano AN, Jones SN. Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis. Cancer Research. 66: 8076-82. PMID 16912184 DOI: 10.1158/0008-5472.Can-06-1451  0.43
2006 Liu Y, Hedvat CV, Mao S, Zhu XH, Yao J, Nguyen H, Koff A, Nimer SD. The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Molecular and Cellular Biology. 26: 3114-23. PMID 16581786 DOI: 10.1128/Mcb.26.8.3114-3123.2006  0.531
2006 Koff A. How to decrease p27Kip1 levels during tumor development. Cancer Cell. 9: 75-6. PMID 16473274 DOI: 10.1016/J.Ccr.2006.01.020  0.358
2006 Liu Y, Miyata Y, Sashida G, Debalsio A, Liu Y, Koff A, Nimer SD. Genetic Uncoupling of the Regulation of Hematopoietic Stem Cell Quiescence and Self-Renewal. Blood. 108: 1347-1347. DOI: 10.1182/Blood.V108.11.1347.1347  0.421
2005 Sakakibara K, Kubota K, Worku B, Ryer EJ, Miller JP, Koff A, Kent KC, Liu B. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. The Journal of Biological Chemistry. 280: 25470-7. PMID 15894805 DOI: 10.1074/Jbc.M502320200  0.504
2005 Vidal A, Zacharoulis S, Guo W, Shaffer D, Giancotti F, Bramley AH, de la Hoz C, Jensen KK, Kato D, MacDonald DD, Knowles J, Yeh N, Frohman LA, Rafii S, Lyden D, ... Koff A, et al. p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow. Proceedings of the National Academy of Sciences of the United States of America. 102: 6890-5. PMID 15867156 DOI: 10.1073/Pnas.0405823102  0.405
2005 Shaffer DR, Viale A, Ishiwata R, Leversha M, Olgac S, Manova K, Satagopan J, Scher H, Koff A. Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate. Proceedings of the National Academy of Sciences of the United States of America. 102: 210-5. PMID 15615849 DOI: 10.1073/Pnas.0407362102  0.479
2004 Zhu XH, Nguyen H, Halicka HD, Traganos F, Koff A. Noncatalytic requirement for cyclin A-cdk2 in p27 turnover. Molecular and Cellular Biology. 24: 6058-66. PMID 15199159 DOI: 10.1128/Mcb.24.13.6058-6066.2004  0.56
2003 Carneiro C, Jiao MS, Hu M, Shaffer D, Park M, Pandolfi PP, Cordon-Cardo C, Koff A. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development. Oncogene. 22: 361-9. PMID 12545157 DOI: 10.1038/Sj.Onc.1206163  0.443
2002 Nguyen TB, Manova K, Capodieci P, Lindon C, Bottega S, Wang XY, Refik-Rogers J, Pines J, Wolgemuth DJ, Koff A. Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin. The Journal of Biological Chemistry. 277: 41960-9. PMID 12185076 DOI: 10.1074/Jbc.M203951200  0.708
2002 Vidal A, Millard SS, Miller JP, Koff A. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. The Journal of Biological Chemistry. 277: 16433-40. PMID 11875067 DOI: 10.1074/Jbc.M112090200  0.553
2002 Mahoney JA, Odin JA, White SM, Shaffer D, Koff A, Casciola-Rosen L, Rosen A. The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. The Biochemical Journal. 361: 587-95. PMID 11802788 DOI: 10.1042/Bj3610587  0.335
2001 Park MS, Koff A. Overview of the cell cycle Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. PMID 18228386 DOI: 10.1002/0471143030.Cb0801S00  0.536
2001 Gitig DM, Koff A. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Molecular Biotechnology. 19: 179-88. PMID 11725487 DOI: 10.1385/Mb:19:2:179  0.804
2001 Cipriano SC, Chen L, Burns KH, Koff A, Matzuk MM. Inhibin and p27 interact to regulate gonadal tumorigenesis Molecular Endocrinology. 15: 985-996. PMID 11376116 DOI: 10.1210/Mend.15.6.0650  0.427
2001 Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A. p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. Embo Reports. 2: 27-34. PMID 11252720 DOI: 10.1093/Embo-Reports/Kve008  0.499
2001 Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, P Pandolfi P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse Nature Genetics. 27: 222-224. PMID 11175795 DOI: 10.1038/84879  0.349
2000 Millard SS, Vidal A, Markus M, Koff A. A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA. Molecular and Cellular Biology. 20: 5947-59. PMID 10913178 DOI: 10.1128/Mcb.20.16.5947-5959.2000  0.437
2000 Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A, Adams JM. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Molecular and Cellular Biology. 20: 4745-53. PMID 10848600 DOI: 10.1128/Mcb.20.13.4745-4753.2000  0.8
2000 Gitig DM, Koff A. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Methods in Molecular Biology (Clifton, N.J.). 142: 109-23. PMID 10806617 DOI: 10.1385/1-59259-053-5:109  0.804
2000 Vidal A, Koff A. Cell-cycle inhibitors: Three families united by a common cause Gene. 247: 1-15. PMID 10773440 DOI: 10.1016/S0378-1119(00)00092-5  0.51
2000 Tsutsui T, Hesabi B, Moons DS, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Molecular and Cellular Biology. 19: 7011-9. PMID 10490638 DOI: 10.1128/Mcb.19.10.7011  0.596
1999 Chou JL, Fan Z, DeBlasio T, Koff A, Rosen N, Mendelsohn J. Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor Breast Cancer Research and Treatment. 55: 267-283. PMID 10517171 DOI: 10.1023/A:1006217413089  0.528
1999 Kolluri SK, Weiss C, Koff A, Göttlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes & Development. 13: 1742-53. PMID 10398686 DOI: 10.1101/Gad.13.13.1742  0.512
1999 Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, Koff A. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proceedings of the National Academy of Sciences of the United States of America. 96: 6382-7. PMID 10339596 DOI: 10.1073/Pnas.96.11.6382  0.435
1999 Beumer TL, Kiyokawa H, Roepers-Gajadien HL, van den Bos LA, Lock TM, Gademan IS, Rutgers DH, Koff A, de Rooij DG. Regulatory role of p27kip1 in the mouse and human testis. Endocrinology. 140: 1834-40. PMID 10098522 DOI: 10.1210/Endo.140.4.6638  0.535
1999 Nguyen H, Gitig DM, Koff A. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Molecular and Cellular Biology. 19: 1190-201. PMID 9891053 DOI: 10.1128/Mcb.19.2.1190  0.794
1998 Millard SS, Koff A. Cyclin-dependent kinase inhibitors in restriction point control, genomic stability, and tumorigenesis. Journal of Cellular Biochemistry. Supplement. 30: 37-42. PMID 9893253 DOI: 10.1002/(Sici)1097-4644(1998)72:30/31+<37::Aid-Jcb6>3.0.Co;2-W  0.362
1998 Tong W, Kiyokawa H, Soos TJ, Park MS, Soares VC, Manova K, Pollard JW, Koff A. The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa->luteal transition. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 9: 787-94. PMID 9751122  0.8
1998 Tikoo R, Osterhout DJ, Casaccia-Bonnefil P, Seth P, Koff A, Chao MV. Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest. Journal of Neurobiology. 36: 431-40. PMID 9733077 DOI: 10.1002/(Sici)1097-4695(19980905)36:3<431::Aid-Neu10>3.0.Co;2-E  0.567
1998 Soos TJ, Park M, Kiyokawa H, Koff A. Regulation of the cell cycle by CDK inhibitors. Results and Problems in Cell Differentiation. 22: 111-31. PMID 9670321 DOI: 10.1007/978-3-540-69686-5_5  0.81
1997 Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 3: 2247-51. PMID 9815621  0.767
1997 Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich V, Chao MV, Koff A. Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes & Development. 11: 2335-46. PMID 9308962 DOI: 10.1101/Gad.11.18.2335  0.435
1997 Millard SS, Yan JS, Nguyen H, Pagano M, Kiyokawa H, Koff A. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. The Journal of Biological Chemistry. 272: 7093-8. PMID 9054402 DOI: 10.1074/Jbc.272.11.7093  0.561
1997 Tikoo R, Casaccia-Bonnefil P, Chao MV, Koff A. Changes in cyclin-dependent kinase 2 and p27kip1 accompany glial cell differentiation of central glia-4 cells. The Journal of Biological Chemistry. 272: 442-7. PMID 8995281 DOI: 10.1074/Jbc.272.1.442  0.539
1997 Luo Y, Marx SO, Kiyokawa H, Koff A, Massagué J, Marks AR. Rapamycin resistance tied to defective regulation of p27Kip1. Molecular and Cellular Biology. 16: 6744-51. PMID 8943329 DOI: 10.1128/Mcb.16.12.6744  0.465
1996 Missero C, Di Cunto F, Kiyokawa H, Koff A, Dotto GP. The absence of p21(Cip1/WAF1) alters keratinocyte growth and differentiation and promotes ras-tumor progression Genes and Development. 10: 3065-3075. PMID 8957006  0.344
1996 Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 7: 135-46. PMID 8822197  0.815
1996 Onel K, Koff A, Bennett RL, Unrau P, Holloman WK. The REC1 gene of Ustilago maydis, which encodes a 3'-->5' exonuclease, couples DNA repair and completion of DNA synthesis to a mitotic checkpoint. Genetics. 143: 165-74. PMID 8722772  0.301
1996 Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85: 721-32. PMID 8646780 DOI: 10.1016/S0092-8674(00)81238-6  0.474
1996 Hoffman ES, Passoni L, Crompton T, Leu TM, Schatz DG, Koff A, Owen MJ, Hayday AC. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes & Development. 10: 948-62. PMID 8608942 DOI: 10.1101/Gad.10.8.948  0.376
1995 Koff A, Polyak K. p27KIP1, an inhibitor of cyclin-dependent kinases Progress in Cell Cycle Research. 1: 141-147. PMID 9552359 DOI: 10.1007/978-1-4615-1809-9_11  0.533
1995 Fan Z, Lu Y, Wu X, DeBlasio A, Koff A, Mendelsohn J. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition Journal of Cell Biology. 131: 235-242. PMID 7559780 DOI: 10.1083/Jcb.131.1.235  0.402
1994 Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest Genes and Development. 8: 9-22. PMID 8288131 DOI: 10.1101/Gad.8.1.9  0.532
1994 Firpo EJ, Koff A, Solomon MJ, Roberts JM. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes Molecular and Cellular Biology. 14: 4889-4901. PMID 7516474  0.436
1993 Koff A, Ohtsuki M, Polyak K, Roberts JM, Massagué J. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-β Science. 260. PMID 8475385 DOI: 10.1126/Science.8475385  0.354
1992 Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (New York, N.Y.). 257: 1689-94. PMID 1388288 DOI: 10.1126/Science.1388288  0.452
Show low-probability matches.